ABK Biomedical, Inc. and COR Development are proud to announce a strategic partnership to develop a state-of-the-art GMP ...
ABK Biomedical is building a Missouri facility to produce Eye90 microspheres, advancing radiopharmaceuticals for liver cancer ...
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
CHASKA, Minn., March 23, 2026 (GLOBE NEWSWIRE)-- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), ...
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial ...
-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial ...
Saladax Biomedical, Inc., a leader in therapeutic drug monitoring (TDM) diagnostics for psychiatry and oncology, today announced a distribution agreement ...
HALIFAX, NS, March 31, 2026 /PRNewswire/ - ABK Biomedical and the University of Missouri Research Reactor (MURR) are powering the next generation of cancer treatment. Today, the two partners signed a ...
US biotech ABK Biomedical has signed a long-term agreement with the University of Missouri Research Reactor (MURR), naming it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results